|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
0.00% | - |
| 12-28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Chart calendar Seelos Therapeutics, Inc.
Upcoming events on Seelos Therapeutics, Inc.
No events available
Past events on Seelos Therapeutics, Inc.
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 2,20 1,55 42.13% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -61,7 -45,1 -36.76% | -70,9 -68,6 -3.33% | -40,5 -39,5 -2.56% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
Net income Million USD | Released Forecast Spread | -66,0 -49,6 -33.16% | -73,5 -70,2 -4.71% | -37,9 -39,4 3.9% |
|
EPS USD | Released Forecast Spread | -2 803 -2 118 -32.33% | -2 650 -2 419 -9.52% | -989 -52,5 -1785.37% |
| Announcement Date | 04/03/22 | 10/03/23 | 06/03/24 |
Quarterly results
| Fiscal Period | June | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,81 0,00 - | 0,34 0,00 - | 0,41 0,00 - | 0,65 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -18,3 -16,0 -14.44% | -8,93 -13,3 32.81% | -11,0 -10,2 -7.09% | -12,6 -11,5 -9.22% | -8,01 -7,00 -14.44% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
Net income Million USD | Released Forecast Spread | -18,7 -16,0 -16.89% | -13,4 -13,2 -1.72% | -29,5 -10,3 -187.65% | 10,5 -11,5 191.12% | -5,45 -6,99 22.01% |
|
EPS USD | Released Forecast Spread | -653 -499 -30.77% | -461 -410 -12.5% | -845 -365 -131.58% | 307 -230 233.33% | -102 |
| Announcement Date | 10/03/23 | 12/05/23 | 11/08/23 | 14/11/23 | 06/03/24 |
| 2026-06-28 |  | Annual General Meeting | 22:00 |
| 2026-06-29 | | Information meeting | 11:30 |
| 2026-06-29 | | Annual General Meeting | 02:00 |
| 2026-06-29 | | Annual General Meeting | |
| 2026-06-29 | | Earnings presentation | 22:00 |
| 2026-06-29 | | Annual General Meeting | 02:00 |
| 2026-06-29 | | Analyst/Investor Day | |
| 2026-06-29 | | Extraordinary General Meeting | |
| 2026-06-29 | | Significant Split/Dividend | 00:00 |
| 2026-06-30 | | Présentation aux Actionnaires / Analystes | 12:00 |
Past sector events for Seelos Therapeutics, Inc.
| 2026-06-26 | | Annual General Meeting | 02:00 |
| 2026-06-25 | | Annual General Meeting | 08:30 |
| 2026-06-24 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-06-24 | | Annual General Meeting | 08:00 |
| 2026-06-23 | | Information meeting | 14:00 |
| 2026-06-23 | | Extraordinary General Meeting | 23:00 |
| 2026-06-23 | | Présentation aux Actionnaires / Analystes | 12:00 |
| 2026-06-22 | | Information meeting | 08:30 |
| 2026-06-22 | | Annual General Meeting | 10:00 |
| 2026-06-22 | | Présentation aux Actionnaires / Analystes | 10:00 |
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
- Calendar Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
